GENESYS2024-01-012024-03-31 GENESYS2024-01-012024-03-31 GENESYS2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member GENESYS2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member GENESYS2024-03-31 GENESYS2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GENESYS2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GENESYS2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member GENESYS2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506109 GENESYS NOTLISTED Genesys International Corporation Limited Equity 2023-04-01 2024-03-31 2024-05-30 2024-05-24 INR Lakhs Yearly 19:30:00 22:00:00 2024-05-30 2024-05-30 true Cash Flow Indirect Declaration of unmodified opinion Single segment Geographical information systems 2024-01-01 2024-03-31 Audited Consolidated 711725000.00 4601000.00 716326000.00 193362000.00 0.00 0.00 109214000.00 14336000.00 111821000.00 46589000.00 475322000.00 241004000.00 0.00 241004000.00 51224000.00 41892000.00 93116000.00 0.00 147888000.00 0.00 0.00 0.00 0.00 147888000.00 -12780000.00 135108000.00 148503000.00 -615000.00 136083000.00 -975000.00 197703000.00 5 3.78 3.75 0.00 0.00 3.78 3.75 1 The Group is engaged in providing advanced geospatial content and solutions including 3D mapping. 2 The Group operates only in one Segment i.e. GIS based services for the purpose of IND AS – 108 Segmental reporting, hence disclosure as per IND AS 108 'Operating Segment' is not required. 3 The audited consolidated financial results have been reviewed and recommended by the Audit Committee. The Board of Directors at its meeting held on May 30, 2024 approved the same. The statutory auditors have expressed an unmodified opinion on these results. 4 The above Statement has been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules there under and in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. 5 The audited consolidated financial results for the three months ended 31 March, 2024 and 31 March, 2023 are the balancing figures between the audited figures for the year then ended and year to date figures upto the third quarter of the respective financial years, which were subject to limited review. 6 The Board of Directors of the Holding Company in its meeting held on 19th December 2022, has, subject to necessary approvals approved the Scheme of Amalgamation for merger of its Wholly Owned Subsidiary, Virtual World Spatial Technologies Private Limited (Transferor Company), with Genesys International Corporation Limited (Transferee Company). Accordingly, a petition under section 230 to 232 of the Companies Act, 2013 was filed with Hon’ble NCLT, Mumbai bench, which is pending. The Scheme shall be made effective from the Appointed date on sanction of Scheme by Hon’ble NCLT and subject to such conditions or guidelines as the Hon’ble NCLT may stipulate in this regard. 7 The Holding Company has incorporated a new wholly owned subsidiary, Genesys Middle East Limited during the Year ended 31st March 2024. 8 Previous period figures have been re-grouped / re-classified, wherever necessary. Single segment 2023-04-01 2024-03-31 Audited Consolidated 1982429000.00 50264000.00 2032693000.00 542570000.00 0.00 0.00 450498000.00 39094000.00 444802000.00 183974000.00 1660938000.00 371755000.00 0.00 371755000.00 103183000.00 52449000.00 155632000.00 0.00 216123000.00 0.00 0.00 0.00 0.00 216123000.00 13000.00 216136000.00 220729000.00 -4606000.00 220729000.00 -4593000.00 197703000.00 5 0.00 5.78 5.74 0.00 0.00 5.78 5.74 Other Expenditure 46589000.00 Other Expenditure 183974000.00 16158000.00 757161000.00 0.00 0.00 0.00 801864000.00 1127397000.00 0.00 0.00 0.00 0.00 3020000.00 74232000.00 77252000.00 221360000.00 38608000.00 3023642000.00 0.00 4000.00 1426705000.00 232674000.00 531099000.00 360000.00 1009000000.00 3199842000.00 9204000.00 113339000.00 3322385000.00 0.00 0.00 6346027000.00 197703000.00 4693918000.00 4891621000.00 4907779000.00 221365000.00 0.00 50408000.00 271773000.00 77962000.00 0.00 0.00 0.00 349735000.00 297326000.00 296485000.00 275164000.00 868975000.00 95075000.00 31972000.00 92491000.00 0.00 1088513000.00 0.00 0.00 1438248000.00 6346027000.00 39095000.00 0.00 -607322000.00 0.00 11236000.00 -6673000.00 -24044000.00 -235834000.00 11000.00 93249000.00 0.00 63896000.00 0.00 444802000.00 0.00 4649000.00 6255000.00 36409000.00 0.00 10296000.00 0.00 8758000.00 31583000.00 0.00 0.00 -12598000.00 0.00 -6840000.00 0.00 -160588000.00 211167000.00 0.00 0.00 0.00 20494000.00 0.00 190673000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1551000.00 326912000.00 0.00 0.00 0.00 407555000.00 0.00 0.00 0.00 102027000.00 0.00 0.00 0.00 0.00 -2892000.00 0.00 0.00 0.00 0.00 5709000.00 0.00 30275000.00 0.00 -796067000.00 0.00 0.00 562498000.00 0.00 0.00 0.00 22681000.00 0.00 194845000.00 0.00 0.00 35061000.00 0.00 32530000.00 0.00 0.00 712433000.00 107039000.00 0.00 107039000.00 125635000.00 232674000.00 Remeasurement of the net defined benefit liabilty/ asset (net of taxes) -882000.00 Remeasurement of the net defined benefit liabilty/ asset (net of taxes) 510000.00 -882000.00 510000.00 0.00 0.00 Exchnage differences on translation of financial statements of forerign operations -11898000.00 Exchnage differences on translation of financial statements of forerign operations -497000.00 -11898000.00 -497000.00 0.00 0.00